Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia
Hemasphere
.
2023 Mar 24;7(4):e870.
doi: 10.1097/HS9.0000000000000870.
eCollection 2023 Apr.
Authors
Constantine Tam
1
,
Javier Munoz
2
,
Gavin Cull
3
4
,
Stephen Opat
5
6
,
Heather Allewelt
7
,
Xiaoping Zhang
7
,
Jennifer C Stern
7
,
James Hilger
7
,
Kunthel By
7
,
Aileen Cohen
7
,
Alessandra Tedeschi
8
Affiliations
1
Alfred Hospital and Monash University, Melbourne, VIC, Australia.
2
Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
3
Sir Charles Gairdner Hospital, Perth, WA, Australia.
4
University of Western Australia, Perth, WA, Australia.
5
Monash Health, Clayton, VIC, Australia.
6
Monash University, Clayton, VIC, Australia.
7
BeiGene, San Mateo, CA, USA.
8
ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
PMID:
36999005
PMCID:
PMC10043571
DOI:
10.1097/HS9.0000000000000870
No abstract available